| Pharmaceutical active ingredients: |
| Chlorpheniramine MaleateCromolyn Sodium |
| Available forms, composition and doses of Visuglican: |
| N / A |
| Visuglican medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AC51 - Cromoglicic acid, combinationsR06AB54 - Chlorphenamine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Visufarma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cromoftol | Chlorpheniramine Maleate; Cromolyn Sodium | Merck |
| Frenal Rinologico | Chlorpheniramine Maleate; Cromolyn Sodium | Sigma-Tau Pharmaceuticals; Monsanto Italiana |
| Rinofrenal | Chlorpheniramine Maleate; Cromolyn Sodium | Balverda |
| Rinofrenal Plus | Chlorpheniramine Maleate; Cromolyn Sodium | Sigma-Tau Pharmaceuticals |
| Rinoglin | Chlorpheniramine Maleate; Cromolyn Sodium | Seber Portuguesa Farmaceutica |
| Scassh Trouch Lozenge | Chlorpheniramine Maleate; Dequalinium Chloride; Dipotassium Glycyrrhizinate; Platycodon Root | Watanabe Pharmaceutical Industrial; Eng An Trading |
| Lergosin A | Chlorpheniramine Maleate; Dexamethasone | Degort's Chemical |
| Visumetazone Antistaminico | Chlorpheniramine Maleate; Dexamethasone | Visufarma |
| Vixidone | Chlorpheniramine Maleate; Dexamethasone | ICN Pharmaceuticals |
| Hem Anth | Chlorpheniramine Maleate; Dexamethasone Phosphate | Llorens |